Screener
Roivant Sciences ROIV Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001635088-26-000090
| Line item | June 30, 2026 | March 31, 2026 |
|---|---|---|
| Common shares, par value $0.0000000341740141 per share, 7,000,000,000 shares authorized and 722,668,062 and 720,352,386 shares issued and outstanding at June 30, 2026 and March 31, 2026, respectively | — | — |
| Additional paid-in capital | 5,130,926 | 5,024,826 |
| Accumulated deficit | (900,354) | (501,814) |
| Accumulated other comprehensive income | 701 | 4,358 |
| Shareholders’ equity attributable to Roivant Sciences Ltd. | 4,231,273 | 4,527,370 |
| Noncontrolling interests | 690,596 | 765,042 |
| Total shareholders’ equity | 4,921,869 | 5,292,412 |
| Total liabilities and shareholders’ equity | $5,306,493 | $5,708,687 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Roivant Sciences's noncontrolling interests in subsidiaries?
- Roivant Sciences (ROIV) reported noncontrolling interests in subsidiaries of $690.6M in Q2 2026.
- How has Roivant Sciences's noncontrolling interests in subsidiaries changed year-over-year?
- Roivant Sciences's noncontrolling interests in subsidiaries increased by 46.9% year-over-year, from $470.27M to $690.6M.
- What is the long-term trend for Roivant Sciences's noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Roivant Sciences's noncontrolling interests in subsidiaries has grown at a 25.9% compound annual growth rate (CAGR), from $241.73M to $765.04M.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.
Ask your AI about Roivant Sciences's noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude